The global mice model market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029.
The Mice Model Market is witnessing significant growth, driven by the rising demand for genetically modified mice in biomedical research. The market size is expanding due to the increasing use of mice models in drug development, cancer research, and neurological studies. This growth is further propelled by advancements in gene-editing technologies, such as CRISPR, which have enhanced the precision and efficiency of creating genetically modified mice.
Market dynamics reveal a strong presence of major pharmaceutical and biotechnology companies investing in mice models to accelerate their research and development processes. The growing prevalence of chronic diseases and the need for personalized medicine are key factors contributing to the market's expansion. Additionally, government funding and grants for research in life sciences are bolstering market growth.
Mice Model Market size
The Mice Model Market size is experiencing robust growth, driven by the increasing utilization of mice models in biomedical research and drug development. With the rising prevalence of chronic diseases and the necessity for personalized medicine, the demand for precise and reliable animal models has surged. Technological advancements in gene-editing tools, particularly CRISPR, have significantly contributed to this expansion by enabling the creation of genetically modified mice with higher precision and efficiency. This burgeoning market is also supported by substantial investments from pharmaceutical and biotechnology companies, alongside government funding aimed at fostering innovative research in life sciences. As research infrastructure continues to improve globally, the Mice Model Market size is expected to maintain its upward trajectory.
Mice Model Market share
-
The Mice Model Market share is diversifying and expanding across various segments due to several key factors:
-
Rising Demand in Pharmaceutical Research: Pharmaceutical companies are increasingly adopting mice models for drug discovery and development, enhancing the market share in this sector.
-
Academic and Research Institutions: A significant portion of the market share is attributed to academic and research institutions that utilize mice models for basic and applied research.
-
Technological Advancements: Innovations such as CRISPR gene-editing technology have allowed for the creation of more sophisticated and specific mice models, increasing their adoption and market penetration.
-
Expansion in Biotechnology: Biotechnology firms are leveraging mice models for the development of novel therapies, further boosting market share.
-
Regulatory Approvals: The approval and support from regulatory bodies for the use of mice models in research contribute to their widespread usage and market dominance.
-
Geographical Distribution: North America holds a substantial share of the market due to advanced research infrastructure, followed by Europe and Asia-Pacific regions where research activities are rapidly growing.
Related Report:
Mice Model Market by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery) - Global Forecast to 2029